You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 17, November 5, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •HIV/AIDS
 •Medical Practice
 •Health Policy
 •World Health
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

President's Emergency Plan for AIDS Relief

Health Development at the Crossroads

Lawrence O. Gostin, JD

JAMA. 2008;300(17):2046-2048.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003, which funded the President's Emergency Plan for AIDS Relief (PEPFAR), was the largest commitment by any nation to combat a single disease in human history, authorizing up to $15 billion over 5 years. On July 30, 2008, President Bush signed into law the historic reauthorization of PEPFAR, dramatically increasing the financial commitment by authorizing up to $48 billion over 5 years, including $5 billion for malaria and $4 billion for tuberculosis. During the signing ceremony, the president said, "There is no way to quantify PEPFAR's greatest achievement: the spread of hope. . . . And spreading hope is in our moral interests—because we believe that to whom much is given, much is required."1 PEPFAR's global targets are inspiring: treat 3 million people; prevent 12 million new human immunodeficiency virus (HIV) infections, and care for 12 million . . . [Full Text of this Article]

Spending Directives: Prevention, Treatment, and Care

Author Affiliation: O’Neill Institute for National and Global Health Law, Georgetown University, Washington, DC.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Obama's victory
Rechel and McKee
BMJ 2009;338:a3082-a3082.
FULL TEXT  

Male Circumcision as an HIV Prevention Strategy in Sub-Saharan Africa: Sociolegal Barriers
Gostin and Hankins
JAMA 2008;300:2539-2541.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.